HPV vaccination in Hong Kong: Implications for medical education

Asian Pacific Journal of Cancer Prevention

Volumn 12, Issue 4, 2011, Pages 1095-1099

  Chan, Zenobia C Y ^a   Chan, T S ^a   Lam, Y M ^a   Lau, L M ^a   Li, K K ^a   Tam, W H ^a  

^a HONG KONG POLYTECHNIC UNIVERSITY   (Hong Kong)

Author keywords

Cervical cancer; General practitioners; Hong Kong; HPV; Vaccines

Indexed keywords

EID: 84856254606     PISSN: 15137368     EISSN: 2476762X     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. Astbury K, Turner MJ (2009). Human papillomavirus Vaccination in the Prevention of Cervical Neoplasia. Int J Gynecol Cancer, 19, 1610-1613.
2. Centres for Disease Control (2010). FDA Licensure of Bivalent Human Papillomavirus Vaccine (HPV2, Cervarix) for Use in Females and Updated HPV Vaccination Recommendations from the Advisory Committee on Immunization Practices (ACIP). MMWR Morb Mortal Wkly Rep, 59, 626-630.
3. Chao C, Slezak JM, Coleman KJ, et al (2009). Papanicolaou Screening Behavior in Mothers and Human Papillomavirus Vaccine Uptake in Adolescent Girls. Am J Public Health, 99, 1137-1142.
4. Colaizzi P (1978). Psychological Research as a Phenomenologist Views it. In 'Existential Phenomenological Alternatives for Psychology', Eds Valle R and King M. Oxford University Press, New York.
5. Conroy K, Rosentha SL, Zimet GD, et al (2009). Human Papillomavirus Vaccine Uptake, Predictors of Vaccination, and Self-reported Barriers to Vaccination. J Womens Health (Larchmt), 18, 1679-1686.
6. Dinh TA, Rosenthal SL, Doan ED, et al (2007). Attitudes of mothers in Da Nang, Vietnam toward a human papillomavirus vaccine. J Adolesc Health, 40, 559-563.
7. Gerend MA, and Barley J (2009). Human papillomavirus vaccine acceptability among young adult men. Sex Transm Dis, 36, 58-62.
8. Gerend MA, Lee SC, Shepherd JE (2007). Predictors of Human Papillomavirus Vaccination Acceptability among Underserved Women. Sex Transm Dis, 34, 468-471.
9. Hakim AA, Lin PS, Wilczynski S, et al (2007). Indications and Efficacy of the Human Papillomavirus Vaccine. Curr Treat Options Oncol, 8, 393-401.
10. National Health Service (2008). HPV Vaccination: Side-effects. [accessed on March 5, 2010]. Available at: http://www.nhs.uk/Conditions/HPV-vaccination/Pages/Side-effects.aspx
11. Ogilvie GS, Remple VP, Marra F, et al (2007). Parental Intention to Have Daughters Receive the Human Papillomavirus Vaccine. Can Med Assoc J, 177, 1506-1512.
12. Polit DF, and Beck CT (2010). 'Essentials of nursing research: appraising evidence for nursing practice', 7th Ed. Wolters Kluwer Health, Lippincott Williams & Wilkins, Philadelphia.
13. Rogers LJ, Eva LJ, Luesley DM (2008). Vaccines against Cervical Cancer. Curr Opin Oncol, 20, 570-574.
14. Satyaprakash A, Creed R, Mendoza N (2009). Human Papillomavirus Vaccines. Dermatol Ther, 22, 150-157.
15. Villa LL, Costa RL, Petta CA, et al. (2006). High Sustained Efficacy of a Prophylactic Quadrivalent Human Papillomavirus Types 6/11/16/18 L1 Virus-like Particle Vaccine through 5 Years of Follow-up. Br J Cancer, 95, 1459-1466.
16. World Health Organization (2008). Cervical Cancer, Human Papillomavirus (HPV), and HPV Vaccines. Key Points for Policy-makers and Health Professionals. [accessed on March 15, 2010]. Available at: http://whqlibdoc.who.int/hq/2008/WHO_RHR_08.14_eng.pdf
17. World Health Organization (2009). Human Papillomavirus (HPV) Position Paper. Wkly Epidemiol Rec, 84, 117-132.